Merck Provides Update on Next Steps for Tredaptive (extended-release niacin/laropiprant)
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jan 11, 2013 - Merck
(NYSE: MRK), known as MSD outside of the United States and Canada,
today announced the company is taking steps to suspend the
availability of TREDAPTIVE™...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials